ES2009251A6 - Un metodo de obtencion de una composicion anticonceptiva para la mujer - Google Patents

Un metodo de obtencion de una composicion anticonceptiva para la mujer

Info

Publication number
ES2009251A6
ES2009251A6 ES8800883A ES8800883A ES2009251A6 ES 2009251 A6 ES2009251 A6 ES 2009251A6 ES 8800883 A ES8800883 A ES 8800883A ES 8800883 A ES8800883 A ES 8800883A ES 2009251 A6 ES2009251 A6 ES 2009251A6
Authority
ES
Spain
Prior art keywords
women
obtaining
contraceptive composition
contraceptive
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8800883A
Other languages
English (en)
Inventor
Michael Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Medical Research Inc
Applied Medical Research Ltd
Original Assignee
Applied Medical Research Inc
Applied Medical Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Medical Research Inc, Applied Medical Research Ltd filed Critical Applied Medical Research Inc
Publication of ES2009251A6 publication Critical patent/ES2009251A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN METODO DE OBTENCION DE UNA COMPOSICION ANTICONCEPTIVA PARA LA MUJER, CARACTERIZADO PORQUE COMPRENDE COMBINAR UNA CANTIDAD ANTICONCEPTIVAMENTE EFICAZ DE MELATONINA CON UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE; Y LLENAR ENTONCES CAPSULAS DE GELATINA CON LA MEZCLA RESULTANTE.
ES8800883A 1987-03-23 1988-03-23 Un metodo de obtencion de una composicion anticonceptiva para la mujer Expired ES2009251A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin

Publications (1)

Publication Number Publication Date
ES2009251A6 true ES2009251A6 (es) 1989-09-16

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8800883A Expired ES2009251A6 (es) 1987-03-23 1988-03-23 Un metodo de obtencion de una composicion anticonceptiva para la mujer

Country Status (26)

Country Link
US (1) US4855305A (es)
EP (1) EP0354921B1 (es)
JP (2) JP2965160B2 (es)
KR (1) KR890700349A (es)
CN (1) CN1041383C (es)
AT (1) ATE143807T1 (es)
AU (3) AU628784B2 (es)
BG (1) BG51075A1 (es)
BR (1) BR8807426A (es)
CA (1) CA1322527C (es)
DD (1) DD269557A5 (es)
DE (1) DE3855606T2 (es)
EG (1) EG18583A (es)
ES (1) ES2009251A6 (es)
FI (1) FI894423A0 (es)
GR (1) GR1002146B (es)
HU (1) HU208487B (es)
IL (1) IL85814A (es)
IN (1) IN166946B (es)
NZ (1) NZ223989A (es)
OA (1) OA09134A (es)
PH (1) PH26709A (es)
PT (1) PT87053B (es)
RU (1) RU2114621C1 (es)
WO (1) WO1988007370A1 (es)
ZA (1) ZA882079B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
IL87574A0 (en) * 1987-08-28 1989-01-31 Regulin Ltd Composition for regulating animal reproduction containing an indole derivative
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
IN170311B (es) * 1989-01-17 1992-03-14 Cohen Michael
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
ATE190490T1 (de) * 1990-09-28 2000-04-15 I F L O S A S Di Giorgio E Ald Kontrazeptives und menstruationszyklus regulierendes präparat mit onkostatischen eigenschaften
EP0518468B1 (en) * 1991-05-09 1999-06-30 Neurim Pharmaceuticals (1991) Limited Melatonin containing compositions
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
JP2001523639A (ja) 1997-11-14 2001-11-27 アクゾ・ノベル・エヌ・ベー プロゲストゲン−抗プロゲストゲンレジメン
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2001286995B2 (en) * 2000-08-30 2006-11-30 Besins Healthcare Luxembourg Sarl Method for treating erectile dysfunction and increasing libido in men
AU2003230644A1 (en) * 2002-03-14 2003-09-29 Ercole L. Cavalieri A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
WO2004091535A2 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
WO2005023241A1 (en) 2003-09-09 2005-03-17 Fumapharm Ag The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
EP1755618A1 (en) * 2004-05-26 2007-02-28 Wyeth a Corporation of the State of Delaware Compositions and methods for treatment of premenstrual dysphoric disorder
SI2801354T1 (sl) 2004-10-08 2017-07-31 Forward Pharma A/S Farmacevtske sestave z nadzorovanim sproščanjem, ki zajemajo ester fumarne kisline
SI1937276T1 (sl) 2005-10-12 2013-04-30 Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road Izboljšani testosteronski gel in postopek uporabe
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
DK2653873T3 (da) 2007-02-08 2022-07-25 Biogen Ma Inc Sammensætninger og anvendelser til behandling af multipel sklerose
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
US11344531B2 (en) * 2014-03-27 2022-05-31 Servicio Andaluz De Salud Durable preparation of an injectable of melatonin exhibiting long-term stability
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
AU5626786A (en) * 1985-03-04 1986-09-24 Cellena (Cell Engineering) A.G. Melatonin compositions and uses thereof
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
IN166946B (es) 1990-08-11
DE3855606T2 (de) 1997-02-13
IL85814A (en) 1992-05-25
FI894423A7 (fi) 1989-09-19
EP0354921A1 (en) 1990-02-21
HUT52954A (en) 1990-09-28
AU5513494A (en) 1994-04-14
FI894423L (fi) 1989-09-19
JPH1171276A (ja) 1999-03-16
KR890700349A (ko) 1989-04-24
NZ223989A (en) 1991-08-27
EP0354921B1 (en) 1996-10-09
IL85814A0 (en) 1990-02-09
AU8693891A (en) 1991-12-19
BR8807426A (pt) 1990-04-10
PT87053B (pt) 1993-09-30
HU208487B (en) 1993-11-29
FI894423A0 (fi) 1989-09-19
PT87053A (pt) 1989-03-30
CN88101379A (zh) 1988-10-05
DD269557A5 (de) 1989-07-05
CN1041383C (zh) 1998-12-30
EP0354921A4 (en) 1991-08-07
AU1683088A (en) 1988-11-02
JP2965160B2 (ja) 1999-10-18
ATE143807T1 (de) 1996-10-15
JPH02502724A (ja) 1990-08-30
CA1322527C (en) 1993-09-28
AU628784B2 (en) 1992-09-24
EG18583A (en) 1993-06-30
ZA882079B (en) 1988-09-15
OA09134A (en) 1991-10-31
US4855305A (en) 1989-08-08
DE3855606D1 (de) 1996-11-14
PH26709A (en) 1992-09-15
RU2114621C1 (ru) 1998-07-10
WO1988007370A1 (en) 1988-10-06
BG51075A1 (en) 1993-02-15
AU676523B2 (en) 1997-03-13
GR1002146B (en) 1996-02-19
GR880100177A (el) 1989-01-31

Similar Documents

Publication Publication Date Title
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
LU88750I2 (fr) VENLAFAXINE et ses dérivés pharmaceutiquement acceptables
DE3171774D1 (en) Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
ES523536A0 (es) "un metodo para preparar una mezcla farmaceutica con liberacion controlada de sustancia activa"
ES2057225T3 (es) Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.
MY101029A (en) Bromocriptine compositions
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
IT1243413B (it) Derivati del glicerolo, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
FI811889A7 (fi) Menetelmä farmaseuttisesti aktiivisten indoli- ja indoliinijohdannaisten valmistamiseksi.
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
PT77793B (en) Process for the preparation of analgesic pharmaceutical compositions containing a combination of 1-(p-chlorobenzlydryl)-4-<2-(2-hydroxyethoxy)-ethyl>-diethylenediamine with one or more non esteroidal antiinflamatory/analgesic agents
IT1183053B (it) Derivati dell'alfa-amino-gamma-butirrolatton e, metodo per prepararli e composizioni farmaceutiche che li contengono
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
AR231074A1 (es) Composicion excipiente para una sustancia ingerible por via oral,y procedimiento para su preparacion
IT8219216A0 (it) Ne e relative composizioni farmaceu composto ad attivita' antiinfiammatiche toria,analgesica e mucoregolatrice, procedimento per la sua preparazio-
IT1235760B (it) Derivati del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8721055A0 (it) Derivati prostaglandinici, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
ITMI911535A0 (it) Derivati di una pirrolo-piridina, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
IT8147925A0 (it) Derivati pirazolidinonici dotati di proprieta' anoressiche,formulazioni farmaceutiche che li contengono eprocedimento per la loro preparazione

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050326